Cargando…
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis
Cryptosporidiosis has emerged as a leading cause of non-viral diarrhea in children under five years of age in the developing world, yet the current standard of care to treat Cryptosporidium infections, nitazoxanide, demonstrates limited and immune-dependent efficacy. Given the lack of treatments wit...
Autores principales: | Love, Melissa S., Beasley, Federico C., Jumani, Rajiv S., Wright, Timothy M., Chatterjee, Arnab K., Huston, Christopher D., Schultz, Peter G., McNamara, Case W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310922/ https://www.ncbi.nlm.nih.gov/pubmed/28158186 http://dx.doi.org/10.1371/journal.pntd.0005373 |
Ejemplares similares
-
Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022) -
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
por: Lunde, Christopher S., et al.
Publicado: (2019) -
Design and Solidification of Fast-Releasing Clofazimine
Nanoparticles for Treatment of Cryptosporidiosis
por: Zhang, Yingyue, et al.
Publicado: (2017) -
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors
por: Jumani, Rajiv S., et al.
Publicado: (2019) -
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
por: Janes, Jeff, et al.
Publicado: (2018)